Four-month-old boy dies after vaccination in Jammikunta

KARIMNAGAR:  A four-month-old boy died an hour after being administered a vaccine, triggering allegations from parents that the death was caused by a reaction. Doctors, however, denied the claim.

The boy, son of Lingala Anji and Harshitha from Papakkapalli village in Jammikunta mandal, was taken to Vavilala Primary Health Centre on Saturday, where he was given RVV-2 and Penta-2 vaccinations.

After returning home, the child fainted. The parents rushed him to a private hospital in Jammikunta, from where he was shifted to Hanumakonda hospital. He, however, died during treatment.

Family members confronted PHC Medical Officer Dr Varuna, alleging the vaccine caused the death as the boy had no prior health problems.

Dr Varuna clarified that there was no issue with the vaccine, noting that two other children received doses from the same batch on Wednesday without any complications. She said a post-mortem would reveal the exact cause of death if the family had doubts.

Related Posts

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

The Team Meticulously averted the Risk of Thrombosis, Husband was Donor Delhi/NCR : Doctors at Yashoda Medicity have successfully performed a high-risk kidney transplant in a 28-year-old woman with Antiphospholipid…

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta, a UK-based clinical stage biotech, is differentiated clinical-stage oncology specialist, increasingly defined by continuing progress with its second-generation pre|CISION tumour-activated Peptide Drug Conjugate (PDC) platform. The lead Gen Two…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Puresta launches EVERQ, AI-powered skin-health platform

Puresta launches EVERQ, AI-powered skin-health platform

Stem cell therapy for autism only in approved clinical trials: Centre

Stem cell therapy for autism only in approved clinical trials: Centre